# FDA 483 - Linde, Inc. dba Praxair, Inc - June 18, 2026

Source: https://www.keypedia.com/records/483/linde-inc-dba-praxair-inc/71badc7c-2534-4705-8268-c70f5943d7e2

> FDA 483 for Linde, Inc. dba Praxair, Inc on June 18, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Linde, Inc. dba Praxair, Inc
- Inspection Date: 2026-06-18
- Product Type: drugs
- Office Name: New York District Office
- Summary: Linde Inc., a medical gas manufacturer in Niagara Falls, NY, was cited for significant deficiencies in its Annual Product Quality Review (APQR) procedures and execution. The firm failed to review a representative number of batches and did not adequately incorporate unplanned deviations or out-of-specification results into their APQRs. These issues structurally hindered the identification of trends and continuous improvement efforts for medical gas quality standards.

## Related Officers

- [Jordan S. Burkdoll](https://www.keypedia.com/people/jordan-s-burkdoll/3e68ac2c-b35d-41d2-8451-309a18dda38c)
- [Michelle Lin](https://www.keypedia.com/people/michelle-lin/ac969b83-c599-4b07-a3f4-1ff54b1e1283)
- [Lauren H. Augustyniak](https://www.keypedia.com/people/lauren-h-augustyniak/bde81fac-921f-494b-969b-38770fceda7e)

Company: https://www.keypedia.com/companies/linde-inc-dba-praxair-inc/e373ec1f-fe25-449c-b9eb-8ccf361ea32e

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d